Aiforia wins new clinical segment client in Turkey

Translation: Original published in Finnish on 12/2/2024 at 4:24 pm EET.

According to a press release, Memorial Hospitals Group in Turkey has selected Aiforia as its partner for AI-assisted clinical diagnostics in pathology. Memorial Hospitals Group is the largest private hospital group in Turkey, serving 75,000 patients annually in 11 hospitals. The collaboration will utilize Aiforia's regulatory-approved clinical AI solutions to analyze biopsies from breast, prostate and lung cancer patients at the Memorial Pathology Center laboratory.

According to the press release, Memorial Pathology is the first pathology laboratory in Turkey with a fully digital workflow and all biopsy samples are digitalized. This phase is required to implement Aiforia's image analysis solutions and is often time-consuming, but with a fully digital setting, the customer could start generating revenue for Aiforia as early as the beginning of 2025. We have included new deals in our forecasts and have been waiting for the company to announce them, so this release does not come as a surprise or put immediate pressure on our forecasts. Of course, the announcement supports our forecasts and is another sign that Aiforia's solution is competitive in the market and that the market development in Europe will continue.